Getinge AB ser. B - Asset Resilience Ratio
Getinge AB ser. B (GETI-B) has an Asset Resilience Ratio of 6.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Getinge AB ser. B PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2025)
This chart shows how Getinge AB ser. B's Asset Resilience Ratio has changed over time. See Getinge AB ser. B balance sheet quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Getinge AB ser. B's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see GETI-B market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr3.40 Billion | 6.02% |
| Short-term Investments | Skr22.00 Million | 0.04% |
| Total Liquid Assets | Skr3.42 Billion | 6.06% |
Asset Resilience Insights
- Limited Liquidity: Getinge AB ser. B maintains only 6.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Getinge AB ser. B Industry Peers by Asset Resilience Ratio
Compare Getinge AB ser. B's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
Annual Asset Resilience Ratio for Getinge AB ser. B (2008–2025)
The table below shows the annual Asset Resilience Ratio data for Getinge AB ser. B.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.06% | Skr3.42 Billion ≈ $368.37 Million |
Skr56.51 Billion ≈ $6.08 Billion |
+1.38pp |
| 2024-12-31 | 4.67% | Skr2.99 Billion ≈ $321.45 Million |
Skr63.92 Billion ≈ $6.88 Billion |
-0.53pp |
| 2023-12-31 | 5.20% | Skr2.79 Billion ≈ $300.03 Million |
Skr53.59 Billion ≈ $5.77 Billion |
-5.84pp |
| 2022-12-31 | 11.05% | Skr5.75 Billion ≈ $618.47 Million |
Skr52.03 Billion ≈ $5.60 Billion |
+1.89pp |
| 2021-12-31 | 9.15% | Skr4.08 Billion ≈ $438.75 Million |
Skr44.55 Billion ≈ $4.79 Billion |
-8.93pp |
| 2020-12-31 | 18.08% | Skr8.14 Billion ≈ $875.67 Million |
Skr45.01 Billion ≈ $4.84 Billion |
+15.25pp |
| 2019-12-31 | 2.83% | Skr1.27 Billion ≈ $136.24 Million |
Skr44.71 Billion ≈ $4.81 Billion |
-0.14pp |
| 2018-12-31 | 2.98% | Skr1.29 Billion ≈ $138.82 Million |
Skr43.35 Billion ≈ $4.67 Billion |
-1.05pp |
| 2017-12-31 | 4.03% | Skr1.70 Billion ≈ $182.52 Million |
Skr42.10 Billion ≈ $4.53 Billion |
+0.68pp |
| 2016-12-31 | 3.34% | Skr1.85 Billion ≈ $198.66 Million |
Skr55.21 Billion ≈ $5.94 Billion |
+3.05pp |
| 2015-12-31 | 0.30% | Skr158.00 Million ≈ $17.00 Million |
Skr53.23 Billion ≈ $5.73 Billion |
-0.20pp |
| 2014-12-31 | 0.50% | Skr264.00 Million ≈ $28.41 Million |
Skr52.82 Billion ≈ $5.68 Billion |
-0.58pp |
| 2013-12-31 | 1.08% | Skr480.00 Million ≈ $51.66 Million |
Skr44.30 Billion ≈ $4.77 Billion |
+0.46pp |
| 2012-12-31 | 0.62% | Skr267.00 Million ≈ $28.73 Million |
Skr42.92 Billion ≈ $4.62 Billion |
-0.55pp |
| 2010-12-31 | 1.17% | Skr405.00 Million ≈ $43.58 Million |
Skr34.59 Billion ≈ $3.72 Billion |
+0.35pp |
| 2009-12-31 | 0.82% | Skr307.00 Million ≈ $33.04 Million |
Skr37.50 Billion ≈ $4.04 Billion |
+0.54pp |
| 2008-12-31 | 0.28% | Skr92.00 Million ≈ $9.90 Million |
Skr33.03 Billion ≈ $3.55 Billion |
-- |
About Getinge AB ser. B
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solu… Read more